Key statistics
On Thursday, Sangamo Therapeutics Inc (SGMO:NSQ) closed at 0.90, -39.19% below its 52-week high of 1.48, set on Feb 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.85 |
---|---|
High | 0.94 |
Low | 0.8431 |
Bid | 0.89 |
Offer | 0.90 |
Previous close | 0.8371 |
Average volume | 3.55m |
---|---|
Shares outstanding | 208.22m |
Free float | 203.47m |
P/E (TTM) | -- |
Market cap | 174.30m USD |
EPS (TTM) | -1.38 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results
- Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases
- Sangamo Therapeutics Announces Second Quarter 2024 Conference Call and Webcast
- Sangamo Therapeutics Reports on Pfizer’s Announcement of Positive Topline Results From Phase 3 Trial of Hemophilia A Gene Therapy Candidate